Bhandari Hosiery Exports Ltd Right Issue 2024
- Published Date: July 08, 2024
- Updated Date: June 17, 2025
- By Team Choice
Bhandari Hosiery Exports Limited Rights Issue 2024 Details
Bhandari Hosiery Exports Limited is launching a Rights Issue worth Rs 48.19 crore, available for subscription from 8 July 2024 to 22 July 2024. Shareholders will be entitled to 15 Rights equity shares for every 32 fully paid-up equity shares they own as of the record date, 19 June 2024. Each share has a face value of Rs. 1, and the issue price is set at Rs. 6.26 per share.
Stay tuned with us for comprehensive details on Bhandari Hosiery Exports Limited's 2024 Rights Issue, including the issue size, entitlement, payment terms, and more.
Objectives of Bhandari Hosiery Exports Rights Issue
The company plans to use the net proceeds from the Rights Issue, after covering issue-related expenses, for the following purposes:
- To fulfill the company's long-term working capital needs.
- For general corporate purposes.
Bhandari Hosiery Exports Limited Rights Issue Of Shares Detail Overview 2024
| Corporate Action | |
|---|---|
| Security Name | Bhandari Hosiery Exports Ltd |
| Issue Open/Close | July 8, 2024 - July 22, 2024 |
| Record Date | June 19, 2024 |
| Issue Size (Amount) | ₹48.19 Crores |
| Issue Size (Shares) | ₹76,611,591 |
| Right Issue Price | ₹6.26 per share |
| Face Value | ₹1 Per Shares |
| CMP | ₹7.92 |
| Renunciation of Rights Entitlements | July 15, 2024 |
| Terms of Payment | The full amount of the Issue Price being Rs. 6.26 will be payable on application |
| Entitlement | 15 Rights Equity Shares for every 32 fully paid-up Equity Shares held on Record Date |
Disclaimer: The Information compiled by CEBPL on a best efforts basis from information CEBPL received from third party vendors, believed to be reliable. The information may contain errors or omissions; and is subject to change without prior or additional notice. CEBPL provides corporate action information that may be of interest or relevance to CEBPL clients. This does not constitute a recommendation or advice by CEBPL, and CEBPL Clients may not rely upon it. CEBPL does not warrant that the information provided is accurate, timely, or complete. CEBPL Clients are urged to verify the information prior to using it in their investing and trading decisions, including, but not limited to, referral to independent financial news resources, company announcements, and regulatory filings or disclosures. "Investment in securities market are subject to market risks, read all the related documents carefully before investing". Registration granted by SEBI and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of retums to investors. Name of Compliance Officer-Prashant Salian Email Id-Prashant.salian@choiceindia.com Contact no. 022-67079999-Ext-2310. Name of Grievance Officer-Deepika Singhvi-Email Id-ig@choiceindia.com, Contact no. 022-67079999-Ext-834. www.choiceindia.com
Recommended for you
FII DII Data - Live Data
Indian Stock Market Prediction For Next Week
10 Best SIP Plans For ₹1000 Per Month in 2025
Pharma Mutual Funds – Best Option to Invest in 2025?
Invest in best pharma mutual funds in India for 2020 with Investica. Explore our top recommended pharma mutual funds to start investing today.